Both in Pharmaceuticals
Nurix Therapeutics vs ANI Pharmaceuticals
Over the past year NRIX returned +30.1% and ANIP returned −24.2%; their daily moves had a correlation of 0.10.
NRIX +30.1% ANIP −24.2%Growth of $1, one year, split-adjusted
| Metric | NRIX | ANIP |
|---|---|---|
| Price | $15.95 | $71.65 |
| Market cap | $1.74B | $1.65B |
| Today | −38.23% | −0.87% |
| 1 month | −29.4% | +0.2% |
| 6 months | −5.5% | −14.8% |
| Year to date | −15.9% | −9.2% |
| 1 year | +26.4% | −23.8% |
| Revenue growth (YoY) | +8426.3% | +25.9% |
| Gross margin | 100.0% | 62.4% |
| Net margin | 81.7% | 8.6% |
| P/E (TTM) | 5.9× | 16.5× |
| Price / sales | 2.5× | 1.7× |
| Net cash | $1.05B | -$234.7M |
| Dividend yield | — | — |
| Volatility (60d) | 104.6% | 26.7% |
| Short % of float | 21.0% | 18.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).